Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GILD | AMGN | CELG | BIIB | VRTX |
| Company | Gilead Sciences Inc | Amgen Inc | Celgene Corp | Biogen Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 66.58 | 270.63 | 108.01 | 198.97 | 404.50 |
| High | 66.89 | 274.42 | 108.59 | 205.75 | 406.83 |
| Low | 66.37 | 269.65 | 107.27 | 198.97 | 399.37 |
| Last | 66.81 | 273.67 | 108.24 | 201.67 | 401.32 |
| Change | -0.22 | +0.13 | +0.11 | +8.49 | -3.59 |
| % Change | -0.33% | +0.05% | +0.10% | +4.39% | -0.89% |
| Volume | 1,925,755 | 443,354 | 191,230,496 | 1,324,687 | 240,994 |
| 20-Day Average Volume | 6,154,460 | 2,069,617 | 16,188,930 | 1,162,359 | 940,817 |
| Previous Close | 67.03 | 273.54 | 108.13 | 193.18 | 404.91 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | No | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 69.06 | 271.58 | 108.17 | 202.17 | 403.22 |
| 20-Day Raw Stochastic | 10.92% | 46.23% | 63.25% | 45.50% | 27.46% |
| 20-Day Relative Strength | 32.07% | 48.72% | 64.69% | 42.97% | 43.87% |
| Weighted Alpha | -21.28 | +11.47 | +46.30 | -34.57 | +15.53 |
| Today's Opinion | 100% Sell | 40% Sell | 100% Buy | 88% Sell | 8% Buy |
| Previous Opinion | 100% Sell | 40% Sell | 100% Buy | 100% Sell | 24% Buy |
| Last Month's Opinion | 88% Sell | 24% Buy | 100% Buy | 100% Sell | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.24% since 04/17/24 | +3.60% since 04/17/24 | -1.97% since 11/13/19 | +5.25% since 04/17/24 | +1.60% since 04/17/24 |
| Low | 65.90 on 04/18/24 | 260.68 on 04/19/24 | 107.27 on 11/20/19 | 189.44 on 04/19/24 | 391.01 on 04/18/24 |
| High | 67.68 on 04/23/24 | 274.48 on 04/23/24 | 110.53 on 11/14/19 | 205.75 on 04/24/24 | 406.86 on 04/23/24 |
| 1-Month | |||||
| %Chg | -8.04% since 03/22/24 | -0.94% since 03/22/24 | +5.14% since 10/18/19 | -7.27% since 03/22/24 | -3.92% since 03/22/24 |
| Low | 65.90 on 04/18/24 | 260.68 on 04/19/24 | 102.40 on 10/21/19 | 189.44 on 04/19/24 | 391.01 on 04/18/24 |
| High | 73.87 on 03/28/24 | 288.57 on 03/28/24 | 110.70 on 11/13/19 | 218.26 on 03/25/24 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | -16.04% since 01/24/24 | -10.45% since 01/24/24 | +13.63% since 08/20/19 | -18.17% since 01/24/24 | -6.59% since 01/24/24 |
| Low | 65.90 on 04/18/24 | 260.68 on 04/19/24 | 93.41 on 08/23/19 | 189.44 on 04/19/24 | 391.01 on 04/18/24 |
| High | 81.06 on 01/25/24 | 329.72 on 02/05/24 | 110.70 on 11/13/19 | 251.99 on 01/31/24 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | -14.56% since 10/24/23 | -0.92% since 10/24/23 | +14.14% since 05/20/19 | -19.78% since 10/24/23 | +8.12% since 10/24/23 |
| Low | 65.90 on 04/18/24 | 249.70 on 10/31/23 | 89.08 on 07/23/19 | 189.44 on 04/19/24 | 341.90 on 11/16/23 |
| High | 87.86 on 01/19/24 | 329.72 on 02/05/24 | 110.70 on 11/13/19 | 268.30 on 01/03/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 83,457,512 | 146,720,288 | 77,035,920 | 28,080,836 | 104,652,640 |
| Shares Outstanding, K | 1,245,077 | 536,376 | 711,714 | 145,361 | 258,459 |
| Annual Sales | 27,116,000,000 | 28,190,000,000 | 15,281,000,000 | 9,835,600,000 | 9,869,200,000 |
| Annual Net Income | 5,665,000,000 | 6,717,000,000 | 4,046,000,000 | 1,161,100,000 | 3,619,600,000 |
| Last Quarter Sales | 7,114,000,000 | 8,196,000,000 | 4,520,000,000 | 2,386,300,000 | 2,517,700,000 |
| Last Quarter Net Income | 1,429,000,000 | 767,000,000 | 1,691,000,000 | 249,700,000 | 968,800,000 |
| 60-Month Beta | 0.19 | 0.58 | 1.41 | -0.02 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.72 on 02/06/24 | 4.71 on 02/06/24 | 2.99 on 10/31/19 | 2.95 on 02/13/24 | 4.20 on 02/05/24 |
| Latest Earnings Date | 04/25/24 | 05/02/24 | 10/31/19 | 04/24/24 | 05/06/24 |
| Most Recent Dividend | 0.770 on 03/14/24 | 2.250 on 02/15/24 | N/A | N/A | N/A |
| Next Ex-Dividends Date | 03/14/24 | 05/16/24 | N/A | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 9.96 | 14.58 | 10.99 | 13.18 | 29.76 |